ePRO, ePatient Diaries, and eCOA Market Outstrip US$ 4,130.35 million by 2028 and to grow at a CAGR of 15.1% COVID-19 Impact and Global Analysis By Type of Solution by The Insight Partners
ePRO, ePatient Diaries, and eCOA Market: Insight
According to our latest study on “ePRO, ePatient Diaries, and eCOA Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type of Solution, Modality, and End User,” the market was valued at US$ 1,342.92 million in 2020 and it is projected to reach US$ 4,130.35 million by 2028; it is expected to grow at a CAGR of 15.1% during 2021–2028. The report highlights trends prevailing in the global ePRO, epatient diaries, and eCOA market, and the factors driving and restraining the market growth.
The usage of electronic Clinical Outcome Assessment (eCOA) is a push toward adapting the ‘new normal’ as it is a method to gather patient data electronically by using technologies such as smart home devices, handheld monitors, wearables, e-diaries, tablets, and web servers to allow the stakeholders (patients, healthy volunteers, investigators and caregivers) in the trials to report outcomes directly and digitally. Although historically COA was only related to the evaluation of Patient-Related Outcomes (PRO), the FDA has now broadened the definition to include PerfO, ClinRO, and ObsRO along with PRO. In simple terms, when the above parameters are reported electronically, they fit under the eCOA spectrum.
Download sample PDF Copy of ePRO, ePatient Diaries, and eCOA Market study at: https://www.theinsightpartners.com/sample/TIPRE00018488/
ePRO, ePatient Diaries, and eCOA Market: Competition Landscape & Key Developments
The growth of the ePRO, epatient diaries, and eCOA market is driven by the increasing demand for EHRs and rising use of smartphones. However, concerns regarding data privacy hinder the market growth. Bracket Global LLC (Signant Health), CRF Health, Inc., ERT Clinical, Medidata Solutions, Inc., ArisGlobal LLC, Health Diary, Pte., Ltd., ICON Plc, PAREXEL International Corporation , OmniComm Systems, Inc., Kayentis, and eClinical Solutions LLC. are among the major companies operating in the market.
eCOA/ePRO platform has substantial benefits for sponsors and CROs, as it reduces administrative burden, mitigates cost, and fastens trials. Such system shows strong results with fewer errors and discrepancies, improved data quality, clearer signals, and standardized accurate studies. The factors such as the increasing adoption of EHR and government regulations mandating the maintenance of health records drive the growth of the ePRO, epatient diaries, and eCOA market.
Growing Demand for Clinical Trials
As per the data provided by Clinicaltrials.gov, 2016 has been a big one for clinical research. There were around 366,000 clinical studies registered globally as of February 2021. Clinical studies are an essential part of drug development worldwide. The number of clinical studies has augmented significantly since there were just 2,119 reported in 2000. Of these, almost half are drug or biological trials (123,806), with 45,501 currently recruiting participants. At present, there are 43 therapeutics in Phase II for COVID-19. Companies engaged in the development are AstraZeneca plc; Arch Biopartners Inc.; Applied Therapeutics Inc.; Apeiron Biologics GmbH; 4D Pharma plc; and AB Science SA. Companies are collaborating with other firms to hasten the development of therapeutics and vaccines. For instance, Eli Lilly partnered with AbCellera to develop vaccines; GSK, Novartis, and MSD are working with the Bill and Melinda Gates Foundation. GSK and Sanofi are working together to develop an adjuvanted COVID-19 vaccine.
Further, the outbreak of COVID-19 has created even greater urgency for clinical trials to become more virtual and deliver a safe, convenient patient experience. Thus, market players are launching new products, thereby driving the adoption of patient centric platforms. For instance, Veeva Systems announced MyVeeva for Patients, a new application for clinical research sites. With capabilities for virtual visits, patient adherence, ePRO, eConsent, eSource, and an easy-to-use ePRO, ePatient Diaries, and eCOA, MyVeeva for Patients will make it easier for clinical research sites to deliver a patient-centric and paperless clinical trial experience for patients and sponsors. Additionally, in January 2021 YPrime, LLC, announced the launch of their fifth-generation electronic clinical outcome assessment (eCOA) platform. Its newest platform features an improved user experience for patients, clinical investigators, sponsors, and CROs. This advanced technology enhances clinical trial efficiency, increases site satisfaction, and improves patient compliance. This release also ensures the delivery of cleaner data, streamlining the clinical trial data collection, and approval process.
ePRO, ePatient Diaries, and eCOA Market: Segmental Overview
Based on type of solution, the ePRO, epatient diaries, and eCOA market is segmented into eCOA (Electronic Clinical Outcome Assessments), ePROs (Patient Reported Outcomes), ClinROs (Clinician Reported Outcomes), ObsROs (Observer Reported Outcomes), PerfOs (Performance Outcomes), E-Patient Diaries. The eCOA segment held the largest share of the market in 2020. However, the ePRO segment is estimated to register the highest CAGR in the market during the forecast period.
Based on modality, the ePRO, epatient diaries, and eCOA market is bifurcated into computer and mobile devices. The mobile devices segment held a larger share of the market in 2020. Also, the same segment is estimated to register a higher CAGR in the market during the forecast period.
Buy Complete Report of ePRO, ePatient Diaries, and eCOA Market Study at: https://www.theinsightpartners.com/buy/TIPRE00018488/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
E-mail: sam@theinsightpartners.com